Immuron

Industry Lists

Immuron Limited (IMC) is an oral immunotherapy research and development and product sales focused on bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases.

Product sales comprise Travelan and Protectyn, used for the prevention of travellers' diarrhoea.

The group is involved in research & development and hyperimmune products (occur predominantly in Australia, the Unites States and Canada).

Contact Details

03 8892 4854

info@immuron.com

www.immuron.com

Lists and Charts

Share Price

Closing price for the last 90 trading days

View Full Chart

Share Transactions

24/11/23

$0 Issued

Paul Brennan

30/06/22

$4k Bought

Daniel Pollock

13/06/22

$0 Other

Stephen Anastasiou

Total value as at the date of the transaction

Revenue

Rank	Company	Revenue
871^st	Immuron	$4.7m
901^st	Range International	$3.2m
902^nd	Lion Selection Group	$3.2m
904^th	Octanex	$3.1m
905^th	Race Oncology	$3.1m

View Full List

1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Total Shareholder Return as at 31/10/23

Rank	Company	1 yr	5 yr
376^th	Octanex	17%	7%
575^th	Lion Selection Group	2%	12%
659^th	Range International	0%	-29%
762^nd	Immuron	-5%	-23%
1697^th	Race Oncology	-62%	54%

1838 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Collapse All Lists and Charts

Company Activity

	NEW ROLE: Flavio Palumbo,	30 Oct 2023
	NEW ROLE: Paul Brennan, Non-Executive Director	13 Apr 2023
	NEW ROLE: Steven Lydeamore, Chief Executive	03 Nov 2022
	NEW ROLE: Thomas Liquard, Former Chief Executive Officer	24 Nov 2020
	NEW ROLE: Jerry Kanellos, Chief Operating Officer	03 Nov 2020
	NEW ROLE: Roger Aston, Non-Executive Chair	03 Nov 2020
	NEW ROLE: Daniel Pollock, Non-Executive Director	03 Nov 2020
	NEW ROLE: Stephen Anastasiou, Non-Executive Director	03 Nov 2020
	NEW ROLE: Peter Anastasiou, Executive Director, Vice Chair	03 Nov 2020